ESTHETICARE
ActiveSummary
ESTHETICARE has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €898,594 and a net result of €234,778. Equity is growing by ~49.3% per year across the filed fiscal years. Its solvency ranks better than 38% of 16810 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability84▼-1
Solvency73▲+4
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €75,000 at 30 days acceptable
Liquidity ample (current ratio 2.31 against 1.63 in 2024; short-term debt: 9.4% and cash: 20.4% of total assets), but 51.8% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
48.2%
Return on assets
12.6%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 12-03-2026, 49 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
49 d early
2024
26 d early
2023
26 d early
2022
31 d early
2021
31 d early
2020
46 d early
2019
44 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 36 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today. Usually files around 30 March (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-09-2026 close30-09-2026 today30-04-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€898,594▲ 10.4%
2024 · €813,816
Total assets
€1.9m▼ 0.2%
2024 · €1.9m
Net result
€234,778▼ 0.6%
2024 · €236,279
Working capital
€230,683▲ 77.6%
2024 · €129,909
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€271,758▲ 145%€282,739▲ 4.0%€422,717▲ 49.5%€347,732▼ 17.7%€345,287▼ 0.7%
Net result€220,883above the sector's middle half▲ 143%€213,051above the sector's middle half▼ 3.5%€271,339above the sector's middle half▲ 27.4%€236,279above the sector's middle half▼ 12.9%€234,778above the sector's middle half▼ 0.6%
Equity€243,148within the sector's middle half▲ 117%€306,199within the sector's middle half▲ 25.9%€577,538above the sector's middle half▲ 88.6%€813,816above the sector's middle half▲ 40.9%€898,594above the sector's middle half▲ 10.4%
Total assets€502,704within the sector's middle half▲ 92.5%€1.2mabove the sector's middle half▲ 141%€1.3mabove the sector's middle half▲ 6.3%€1.9mabove the sector's middle half▲ 44.9%€1.9mabove the sector's middle half▼ 0.2%
Debt€259,557▲ 74.3%€906,393▲ 249%€711,345▼ 21.5%€1.1m▲ 48.2%€965,417▼ 8.4%
Working capital€26,145within the sector's middle half-€50,608below the sector's middle half€44,200within the sector's middle half€129,909within the sector's middle half▲ 194%€230,683within the sector's middle half▲ 77.6%
Solvency48.4%within the sector's middle half▲ 5.4pp25.3%below the sector's middle half▼ 23.1pp44.8%within the sector's middle half▲ 19.6pp43.6%within the sector's middle half▼ 1.2pp48.2%within the sector's middle half▲ 4.6pp
Current ratio1.16below the sector's middle half▲ 0.210.83below the sector's middle half▼ 0.341.29below the sector's middle half▲ 0.461.63within the sector's middle half▲ 0.342.31within the sector's middle half▲ 0.69
Return on assets (ROA)43.9%above the sector's middle half▲ 9.2pp17.6%within the sector's middle half▼ 26.4pp21.1%within the sector's middle half▲ 3.5pp12.6%within the sector's middle half▼ 8.4pp12.6%within the sector's middle half▼ 0.1pp
Staff (FTE)11=1.3▲ 30.0%0.8▼ 38.5%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 1% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.9m
Fixed assets
€1.5m ▼ 4.8%
Current assets
€406,138 ▲ 20.5%
Equity and liabilities €1.9m
Equity
€898,594 ▲ 10.4%
Debt
€965,417 ▼ 8.4%
Debt's share of the balance-sheet total falls from 56.4% to 51.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€503,634▲
2024 · €487,402
Cash flow
€393,125▲
2024 · €375,948
Quick ratio
2.25▲
2024 · 1.50
Debt to equity
1.07▼
2024 · 1.30
ROE
26.1%▼
2024 · 29.0%
Interest coverage
13.28▲
2024 · 11.72
Debt ≤ 1 year
€175,455▼
2024 · €207,193
Debt > 1 year
€789,962▼
2024 · €847,209
Income taxes
€72,924▲
2024 · €70,387
Staff costs
€40,901▼
2024 · €59,776
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 34,696 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.7%
went bankrupt
3.9%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 34,696 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €23,695 | €45,377 | €59,776 | €40,901 | ▼ 31.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €41,519 | €69,611 | €86,114 | €139,670 | €158,347 | ▲ 13.4% |
| Other operating charges640/8 | - | €3,303 | €4,677 | €7,241 | €6,960 | ▼ 3.9% |
| Gross operating margin9900 | €314,894 | €379,349 | €558,885 | €554,419 | €551,496 | ▼ 0.5% |
| Operating profit (loss)9901 | €271,758 | €282,739 | €422,717 | €347,732 | €345,287 | ▼ 0.7% |
| Financial income75/76B | - | €414 | €1 | €506 | €350 | ▼ 30.9% |
| Recurring financial income75 | €95 | €414 | €1 | €506 | €350 | ▼ 30.9% |
| Financial charges65/66B | - | €11,459 | €65,256 | €41,572 | €37,934 | ▼ 8.8% |
| Recurring financial charges65 | €1,861 | €11,459 | €65,256 | €41,572 | €37,934 | ▼ 8.8% |
| Profit (loss) for the period before taxes9903 | €269,992 | €271,694 | €357,461 | €306,666 | €307,702 | ▲ 0.3% |
| Income taxes67/77 | €49,109 | €58,643 | €86,122 | €70,387 | €72,924 | ▲ 3.6% |
| Profit (loss) for the period9904 | €220,883 | €213,051 | €271,339 | €236,279 | €234,778 | ▼ 0.6% |
| Profit (loss) for the period to be appropriated9905 | €220,883 | €213,051 | €271,339 | €236,279 | €234,778 | ▼ 0.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €502,704 | €1.2m | €1.3m | €1.9m | €1.9m | ▼ 0.2% |
| Fixed assets21/28 | €316,973 | €971,206 | €1.1m | €1.5m | €1.5m | ▼ 4.8% |
| Tangible fixed assets22/27 | €316,973 | €970,906 | €1.1m | €1.5m | €1.5m | ▼ 4.8% |
| Land and buildings22 | - | €605,405 | €609,261 | €1.0m | €1.0m | ▼ 3.6% |
| Plant, machinery and equipment23 | - | €198,105 | €216,256 | €260,668 | €272,727 | ▲ 4.6% |
| Furniture and vehicles24 | - | €19,199 | €115,693 | €97,209 | €72,768 | ▼ 25.1% |
| Other tangible fixed assets26 | - | €148,197 | €149,533 | €128,171 | €104,592 | ▼ 18.4% |
| Financial fixed assets28 | - | €300 | €300 | €600 | €600 | = |
| Current assets29/58 | €185,731 | €241,386 | €197,840 | €337,102 | €406,138 | ▲ 20.5% |
| Stocks and contracts in progress3 | €14,901 | €29,084 | €14,544 | €25,709 | €11,042 | ▼ 57.0% |
| Stocks30/36 | - | €29,084 | €14,544 | €25,709 | €11,042 | ▼ 57.0% |
| Amounts receivable within one year40/41 | €15,300 | €6,777 | €40,381 | €22,191 | €10,191 | ▼ 54.1% |
| Trade receivables40 | - | €4,170 | €36,434 | €11,683 | €8,580 | ▼ 26.6% |
| Other amounts receivable41 | - | €2,607 | €3,947 | €10,508 | €1,612 | ▼ 84.7% |
| Cash at bank and in hand54/58 | €153,811 | €203,389 | €140,003 | €286,772 | €380,758 | ▲ 32.8% |
| Deferred charges and accrued income490/1 | - | €2,136 | €2,913 | €2,430 | €4,146 | ▲ 70.7% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €502,704 | €1.2m | €1.3m | €1.9m | €1.9m | ▼ 0.2% |
| Equity10/15 | €243,148 | €306,199 | €577,538 | €813,816 | €898,594 | ▲ 10.4% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €224,548 | €287,599 | €558,938 | €795,216 | €879,994 | ▲ 10.7% |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Distributable reserves133 | - | €285,739 | €557,078 | €793,356 | €878,134 | ▲ 10.7% |
| Profit (loss) carried forward14 | - | €0 | €0 | - | €0 | - |
| Amounts payable17/49 | €259,557 | €906,393 | €711,345 | €1.1m | €965,417 | ▼ 8.4% |
| Amounts payable after more than one year17 | €99,970 | €614,399 | €557,385 | €847,209 | €789,962 | ▼ 6.8% |
| Financial debts170/4 | - | €614,399 | €557,385 | €847,209 | €787,962 | ▼ 7.0% |
| Other amounts payable178/9 | - | - | - | - | €2,000 | - |
| Amounts payable within one year42/48 | €159,587 | €291,994 | €153,640 | €207,193 | €175,455 | ▼ 15.3% |
| Current portion of amounts payable after more than one year42 | - | €56,713 | €57,014 | €68,173 | €59,246 | ▼ 13.1% |
| Trade debts44 | €19,423 | €3,635 | €13,575 | €38,731 | €27,915 | ▼ 27.9% |
| Suppliers440/4 | - | €3,635 | €13,575 | €38,731 | €27,915 | ▼ 27.9% |
| Taxes, remuneration and social security45 | - | €11,341 | €18,390 | €64,681 | €53,470 | ▼ 17.3% |
| Taxes450/3 | - | €8,202 | €12,582 | €58,169 | €48,385 | ▼ 16.8% |
| Remuneration and social security454/9 | - | €3,139 | €5,808 | €6,512 | €5,085 | ▼ 21.9% |
| Other amounts payable47/48 | - | €220,305 | €64,662 | €35,608 | €34,823 | ▼ 2.2% |
| Accrued charges and deferred income492/3 | - | - | €320 | €0 | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €220,883 | €213,051 | €271,339 | €236,279 | €234,778 | ▼ 0.6% |
| + Depreciation and write-downs630 | €41,519 | €69,611 | €86,114 | €139,670 | €158,347 | ▲ 13.4% |
| Operating cash flow (approximation) | €262,402 | €282,662 | €357,453 | €375,948 | €393,125 | ▲ 4.6% |
| Investment in fixed assets (approximation) | - | -€723,844 | -€205,951 | -€579,744 | -€85,105 | ▲ 85.3% |
| Change in cash | - | €49,579 | -€63,386 | €146,770 | €93,986 | ▼ 36.0% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
12-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
04-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
04-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-09
Financial
Highest result since 2018net €271,339 ▲27.4%
Operating result €422,717, net result €271,339, both a record.
30-09
Financial
Equity above €500,000Eq €577,538 ▲88.6%
6 profitable years in a row build equity to €577,538.
30-03
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-09
Financial
Equity above €200,000Eq €243,148 ▲117%
4 profitable years in a row build equity to €243,148.
15-03
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
17-03
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
30-09
Financial
Liquidity times 8current ratio 4.25
Current ratio from 0.53 to 4.25; short-term debt falls from €33,038 to €24,191.
30-09
Financial
Equity above €100,000Eq €144,241 ▲162%
2 profitable years in a row build equity to €144,241.
Show earlier events
03-04
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
05-04
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
24-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zoersel · 3 establishment units since 2016
Ground area
3,095 m²
Building footprint
1,070 m²
Volume, LiDAR
3,432 m³
3 parcels, Flanders · tallest building 17.2 m, ±2 floors. Linked by address, not a title deed.
3 establishment units
Estheticare
since 20162.251.810.260
Estheticare
since 20222.325.469.783
Estheticare
since 20242.360.808.566
3 parcels
Flanders
3
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11017A0009/00Z000 | Flanders | 2,016 m² | 1 · 324 m² | 8.6 m · 2 fl. |
| 11922C0062/00C004 | Flanders | 626 m² | 1 · 294 m² | 10.2 m · 1 fl. |
| 31013C0606/00A000 | Flanders | 452 m² | 1 · 452 m² | 17.2 m |
Linked by address, not proof of ownership
Good to know
3 of 3 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
254900MDVMJV4SOIO205
Similar companies · same sector, comparable size
Dr. W. Heggermont, cardiologie
BE 0689.768.483
Aalst · Eq €899,013
BUVAMED
BE 0716.921.654
Genk · Eq €897,642
DR. BENOIT VANHOVE
BE 0876.865.647
Aalter · Eq €899,552
CENTRE MONTOIS DE RECHERCHESUR LES ARTHRITES
BE 0860.793.044
Jurbise · Eq €897,186
Dokter Saskia CARTON,gastro-enterologie
BE 0891.371.503
Sint-Katelijne-Waver · Eq €900,450
Of 16,625 companies in sector 86220 we hold annual accounts for 7,987. 5,897 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded01-04-2016
Fiscal year end30-09
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0650972839
Also
9925:BE0650972839
Registered
19-09-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.